Articles dans des revues avec comité de lecture (14)
  1. 1. Kalyvas, C., Papadimitropoulou, K., Malbecq, W., & Spineli, L. (2023). Dealing with censoring in a network meta-analysis of time-to-event data. Research Methods in Medicine & Health Sciences. doi:10.1177/26320843231190026
  2. 2. Oddens, B., Agaku, I., Snyder, E. S., Malbecq, W., Wang, W. W., Kaplan, K., Koch, G., & Rockhold, F. (2022). Exploratory analyses of clinical trial data used for health technology assessments: a retrospective evaluation. BMJ open, 12(7), e058146. doi:10.1136/bmjopen-2021-058146
  3. 3. Jander, N., Minners, J., Holme, I., Gerdts, E., Boman, K., Brudi, P., Chambers, J., Egstrup, K., Kesäniemi, A., Malbecq, W., Nienaber, C., Ray, S., Rossebø, A., Pedersen, T. R., Skjærpe, T., Willenheimer, R., Wachtell, K., Neumann, F.-J., & Gohlke-Bärwolf, C. (2011). Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction. Circulation, 123(8), 887-895. doi:10.1161/CIRCULATIONAHA.110.983510
  4. 4. Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, A. Y., Malbecq, W., Nienaber, C. A., Ray, S., Skjaerpe, T., Wachtell, K., Willenheimer, R., & SEAS Investigators, (2008). Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. The New England journal of medicine, 359(13), 1343-1356. doi:10.1056/NEJMoa0804602
  5. 5. Saper, J., Dahlof, C., So, Y., Tfelt-Hansen, P., Malbecq, W., Loeys, T., Barraclough, E., Klipfel, M., Lines, C. C., Visser, H. W., Reines, S. S., Yuen, E., & Rofecoxib Protocol 162 Study Group, (2006). Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial. Headache, 46(2), 264-275. doi:10.1111/j.1526-4610.2006.00334.x
  6. 6. Brandes, J. L., Visser, H. W., Farmer, M. M., Schuhl, A. L., Malbecq, W., Vrijens, F., Lines, C. C., Reines, S. S., & Protocol 125 study group, (2004). Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache, 44(6), 581-586. doi:10.1111/j.1526-4610.2004.446006.x
  7. 7. Muls, E., Autier, P., Malbecq, W., & Vansant, G. (1997). Coronary heart disease risk factors and LDL cholesterol-lowering efficacy of fibrates and simvastatin. Clinical drug investigation, 14(2), 98-108.
  8. 8. Cheng, H., Amin, R., Rogers, J. D., Leff, J. J., Gertz, B. B., Noonan, N., De Smet, M., Malbecq, W., Meisner, D., & Somers, G. (1996). Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharmaceutical research, 13(3), 445-448. doi:10.1023/A:1016056912698
  9. 9. De Prins, J., Cornélissen, G., & Malbecq, W. (1985). Statistical procedures in chronobiology and chronopharmacology. Annual Review of Chronopharmacology, Vol. 2, 27-141.
  10. 10. Reinberg, A., Andlauer, P., De Prins, J., Malbecq, W., Vieux, N., & Bourdeleau, P. (1984). Desynchronization of the oral temperature circadian rhythm and intolerance to shift work. Nature (London), 308(5956), 272-274. doi:10.1038/308272a0
  11. 11. Malbecq, W. (1982). C.G. GEMIGNAGNI. Calculus and statistics. Addison-Wesley publishing Company, Inc. (1970). XI + 353 pages. Relié. Bulletin de la Société mathématique de Belgique. Série A, 34(2), 193-194.
  12. 12. Malbecq, W. (1982). F.C. POWELL. Statistical tables for the social, biological and physical sciences. Cambridge University Press (1982). 96 pages. Relié £ 7,50 ; broché £ 2,95. Bulletin de la Société mathématique de Belgique. Série A, 34(2), 187.
    13. << Précédent 1 2 Suivant >>